BioSpace News Archive

BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, today announced the Company will present four posters at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting taking place November 3-5, 2023 at the San Diego Convention Center in San Diego, CA.

The process began in 2019 when the Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, launched SMASH Packaging.

SG Austria (“Austrianova”), a leading provider of cell biological products and services, today announced that it has established a German subsidiary company based in Munich and moved to a new location in Singapore.

Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday, November 9, 2023 to discuss Medexus’s results for its second fiscal quarter ended September 30, 2023.

The Board of Directors of Swedish Orphan Biovitrum AB has, as previously communicated, on 31 October 2023 resolved to issue redeemable and convertible series C shares and to, conditional upon subscription and payment from Svenska Handelsbanken AB, repurchase all issued series C shares, to secure Sobi’s obligations under the outstanding incentive programmes.

Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR) today announced that members of the company’s management team will participate in a fireside chat and 1x1 investor meetings at the Guggenheim 5th Annual Inflammation, Neurology & Immunology Conference, taking place in New York, NY from November 6 - 7, 2023.

RAPT Therapeutics, Inc. announced that members of the RAPT management team will participate in the following investor conferences in November.

X4 Pharmaceuticals, a company driven to improve the lives of people with rare diseases of the immune system, announced that, effective on October 31, 2023, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan.

Regeneron Pharmaceuticals, Inc. announced long-term outcomes and new analyses of pivotal clinical data for EYLEA® HD Injection 8 mg will be presented at the American Academy of Ophthalmology annual meeting in San Francisco from November 3 to 6.

Aadi Bioscience, Inc. (NASDAQ: AADI) today announced that it will host a conference call and live webcast on Wednesday, November 8, 2023 at 8:30 am ET (5:30 am PT) to report third quarter 2023 financial results and provide an operational update.